Clinical Immunology & Research

Clinical Immunology & Research

Open Access
ISSN: 2639-8494
Case Report

Plant-Based Stem Cell Immunotherapy for Five Cancer Patients, with Age Reversal and Improved Quality of Life without Exorbitant Costs

Authors: Pichaet Wiriyachitra, Valairat Dhamcharee, Santi Chunthatul, Preeya Leelahagul, Sakda Sreesangkom

DOI: 10.33425/2639-8494.1072


Abstract

We report here five cancer cases, consisting of follicular lymphoma, colon cancer, ovarian cancer, and two cases of lung cancer, in which the patients were concerned about the side effects of chemotherapy and opted instead to use APCO innovation, Fortified Mangosteen Extract (FME), a plant-based stem cell immunotherapy. The treatment was administered over a 12-week period, with clinical follow-up and assessment of treatment outcomes. Across these cases, the patients became cancer-free without observed side effects. All patients also reported an improved quality of life compared with the period before their cancer diagnosis. In three patients, telomere length was found to have increased, indicating biological age reversal.

View / Download PDF
Citation: Pichaet Wiriyachitra, Valairat Dhamcharee, Santi Chunthatul, et al. Plant-Based Stem Cell Immunotherapy for Five Cancer Patients, with Age Reversal and Improved Quality of Life without Exorbitant Costs. Clin Immunol Res. 2026; 10(1). DOI: 10.33425/2639-8494.1072
Editor-in-Chief
Jianxun Song
Jianxun Song
Microbial Pathogenesis & Immunology | Pennsylvania State University

View full editorial board →
Journal Metrics
Impact Factor 2.4*
Acceptance Rate 74%
Time to first decision 6-10 Days
Submission to acceptance 12-15 Days